Praxis Precision Medicines (PRAX) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Praxis Precision Medicines insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $44.3M of PRAX stock on the open market.
Get emailed when insiders cluster-buy stocks like PRAX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PRAX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $3.6M | 12 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $40.7M | 16 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Praxis Precision Medicines, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $44.3M. 12 of 28 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 2,8545,961 held (−32%) | $311.91 | $890K | -16.7% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 1,7508,815 held (−17%) | $310.89 | $544K | -16.4% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 1,2793,174 held (−29%) | $314.90 | $403K | -17.5% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 1,24011,564 held (−10%) | $308.24 | $382K | -15.7% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 1,0044,957 held (−17%) | $312.83 | $314K | -16.9% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 99910,565 held (−9%) | $309.38 | $309K | -16.0% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 8372,337 held (−26%) | $315.71 | $264K | -17.7% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 68312,804 held (−5%) | $306.77 | $210K | -15.3% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 5044,453 held (−10%) | $313.66 | $158K | -17.2% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 32013,487 held (−2%) | $305.31 | $98K | -14.9% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 12013,807 held (−1%) | $303.13 | $36K | -14.3% | — |
| Jun 26SEC | Jill DesimoneDirector | Sell Plan | 1013,927 held (−0%) | $301.44 | $3K | -13.8% | — |
| Nov 21SEC | Alex NemiroffGeneral Counsel | Sell | 13,33930,909 held (−30%) | $192.53 | $2.6M | +35.0% | — |
| Nov 21SEC | Lauren MastrocolaPrincipal Accounting Officer | Sell | 11,45512,587 held (−48%) | $191.96 | $2.2M | +35.4% | — |
| Nov 21SEC | Alex NemiroffGeneral Counsel | Sell | 9,10020,832 held (−30%) | $194.30 | $1.8M | +33.7% | — |
| Nov 21SEC | Lauren MastrocolaPrincipal Accounting Officer | Sell | 2,14510,442 held (−17%) | $192.71 | $413K | +34.8% | — |
| Nov 21SEC | Alex NemiroffGeneral Counsel | Sell | 1,71444,248 held (−4%) | $190.86 | $327K | +36.2% | — |
| Nov 21SEC | Alex NemiroffGeneral Counsel | Sell | 97729,932 held (−3%) | $193.23 | $189K | +34.5% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 250,0002,081,829 held (−11%) | $104.31 | $26.1M | +149.1% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 27,2872,331,829 held (−1%) | $101.00 | $2.8M | +157.3% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 19,1982,060,175 held (−1%) | $140.00 | $2.7M | +85.6% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 12,6002,361,485 held (−1%) | $90.00 | $1.1M | +188.7% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 1,6612,080,168 held (−0%) | $130.10 | $216K | +99.7% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 1,3632,359,675 held (−0%) | $92.03 | $125K | +182.4% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 4872,079,681 held (−0%) | $131.64 | $64K | +97.4% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 5592,359,116 held (−0%) | $100.11 | $56K | +159.6% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 3082,079,373 held (−0%) | $132.19 | $41K | +96.6% | — |
| Oct 17SEC | Phillip Gross10% Owner | Sell | 4472,361,038 held (−0%) | $91.04 | $41K | +185.4% | — |
Insiders at Praxis Precision Medicines, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Phillip Gross10% Owner | — | $33.2M | Oct 17, 2025 | — |
| Alex NemiroffGeneral Counsel | — | $4.9M | Nov 21, 2025 | — |
| Jill DesimoneDirector | — | $3.6M | Jun 26, 2026 | — |
| Lauren MastrocolaPrincipal Accounting Officer | — | $2.6M | Nov 21, 2025 | — |
PRAX stock: common questions
Are Praxis Precision Medicines, Inc. insiders buying PRAX stock?
In the past 12 months, 0 insiders reported open-market purchases of PRAX worth $0.
Are Praxis Precision Medicines, Inc. insiders selling PRAX stock?
4 insiders reported sales worth $44.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PRAX's 52-week range?
Over the past year PRAX has traded between $52.34 and $386.33. It last closed at $259.86 on Oct 9, 2026.